Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,366.80
176.50 (8.06%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.40K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
252.2
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹990.1+139.0%
52W High₹2,395-1.2%
Current Price
₹2,366.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,893.44
Upper Circuit₹2,840.16
Reference Price
₹2,366.80
Investment Checklist
3-day momentum: +14.4% — strong upward pressure
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
RSI at 71.7 — overbought, pullback risk
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
50%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
2026.99
EMA50
1766.58
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows5
Lower Highs7
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹2250.00
₹1768.90
₹1677.22
₹1590.10
₹1512.20
Volume Analysis
TrendDECREASING
Change-54.80%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹2343.13
3% Risk₹2295.80
5% Risk₹2248.46
7% Risk (Custom)
₹2201.12Technical Levels
1x ATR (Volatility)₹2233.68
2x ATR (Swing)₹2100.56
3x ATR (Trend)₹1967.44
Immediate Support₹2250.00
Moving Averages
EMA 9 (Short-term)₹2154.29
EMA 20 (Medium-term)₹2026.99
EMA 50 (Trend)₹1766.58
Financials
Financial Analysis
| Metric | Mar '22 | Mar '23 | Mar '24 | Mar '25 |
|---|---|---|---|---|
| Revenue | ₹183.8 Cr | ₹227.1 Cr | ₹295.7 Cr | ₹362.4 Cr |
| Net Profit | ₹24.8 Cr | ₹30.7 Cr | ₹36.4 Cr | ₹42.4 Cr |
| EPS | ₹24.59 | ₹30.43 | ₹37.90 | ₹42.02 |
| Operating Profit | ₹43.3 Cr | ₹53.7 Cr | ₹61.2 Cr | ₹76.2 Cr |
ROE
21.52%
ROCE
19.01%
Debt/Equity
0.70
Current Ratio
3.22
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Beta Drugs Limited | ₹2,366.80 | +8.06% | 252.2 | ₹2.40K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 23 Sept 2024 | ANNUAL GENERAL MEETING | AGM |
| 22 Sept 2023 | ANNUAL GENERAL MEETING | AGM |
| 20 Sept 2022 | ANNUAL GENERAL MEETING | AGM |
| 21 Sept 2021 | ANNUAL GENERAL MEETING | AGM |
| 21 Sept 2020 | ANNUAL GENERAL MEETING | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for BETA
View All
neutral
Google News - Investing.com India 13h ago
Why is BETA Technologies stock surging today? - Investing.com India
Why is BETA Technologies stock surging today?Investing.com India
BETAHealthcare
neutral
NDTV Profit 12d ago
Elon Musk Unveils Grok 4.5 Private Beta, Claims AI Rivals Claude Opus
The V9 foundation model, which Musk first disclosed in May, finished training at 1.5 trillion parameters.
BETAHealthcare
neutral
Google News - Investing.com India 17d ago
Beta technologies CEO Kyle Clark sells $712,935 in company stock By Investing.com - Investing.com India
Beta technologies CEO Kyle Clark sells $712,935 in company stock By Investing.comInvesting.com India
BETAHealthcare